Thus, in these two unrelated datasets from patients affected by early-onset MM, we observe a very similar down-regulation of most glycolytic pathway enzymes as observed in our mfn1,2 model, with the same orthologous proteins (e.g., SLC2A1, HK2, and LDHB) as exceptions to this trend. This evidence concerns the gene MFN1 and Miyoshi myopathy.